Stephen P. Squinto

Insider Reports History

Location
C/O Alexion Pharmaceuticals Inc, 352 Knotter Drive, Cheshire, CT
Signature
/s/ Francis I. Perier, Jr as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen P. Squinto:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SpringWorks Therapeutics, Inc. Director, 10%+ Owner Common Stock 6.19M $257M $41.53 May 19, 2022 Indirect
SpringWorks Therapeutics, Inc. Director, 10%+ Owner Common Stock 132K $5.47M $41.53 May 19, 2022 Direct
Compass Therapeutics, Inc. Director Stock Option (Right to Buy) 30K Feb 18, 2022 Direct
SpringWorks Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 15.3K May 19, 2022 Direct

Insider Reports Filed by Stephen P. Squinto

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SWTX SpringWorks Therapeutics, Inc. May 19, 2022 2 $0 4 May 20, 2022 Director, 10%+ Owner
CMPX Compass Therapeutics, Inc. Feb 18, 2022 1 $0 4 Feb 23, 2022 Director
SWTX SpringWorks Therapeutics, Inc. May 20, 2021 2 $0 4 May 21, 2021 Director, 10%+ Owner